In vitro activities of irloxacin and E-3846, two new quinolones.
AUTOR(ES)
García-Rodríguez, J A
RESUMO
Irloxacin and E-3846 are two new fluorinated quinolones. We evaluated the activities of these antimicrobial agents, ciprofloxacin, ofloxacin, enoxacin, pefloxacin, norfloxacin, and nalidixic acid against 1,161 bacterial strains. Ciprofloxacin was the most active quinolone. Irloxacin did not show great activity. The activity of E-3846 against gram-negative bacteria was similar to those of ofloxacin and pefloxacin, and E-3846 was the most active quinolone against gram-positive bacteria and anaerobes.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=171797Documentos Relacionados
- In vitro evaluation of A-56619 and A-56620, two new quinolones.
- Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.
- Mycobacteria and the new quinolones.
- In vitro activities of new quinolones against Helicobacter pylori.
- In Vitro Activities of New Quinolones and Oxazolidinones against Actinomadura madurae